A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TI / Technosphere Insulin

[Related PubMed/MEDLINE]
Total Number of Papers: 28
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TI  (>> Co-occurring Abbreviation)
Long Form:   Technosphere Insulin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study. CGM, MDI, PPG, PPGE, TIR
2017 A Population Dose-Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects. GIR, RHI
2017 Inhaled Insulin: A Clinical and Historical Review. ---
2017 Safety of Technosphere Inhaled Insulin. HbA1c
2016 Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator. PPG, UVA
2016 Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need? RAAs
2016 Place of technosphere inhaled insulin in treatment of diabetes. HbA1c
2016 Technosphere insulin: inhaled prandial insulin. ---
2015 AFREZZA (insulin human) Inhalation Powder: A Review in Diabetes Mellitus. ---
10  2015 Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion. zone-MPC
11  2015 Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes Simulator. ---
12  2015 Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial. ---
13  2015 Technosphere insulin (Afrezza): a new, inhaled prandial insulin. ADA, EASD, FEV1
14  2013 In silico evaluation of an artificial pancreas combining exogenous ultrafast-acting technosphere insulin with zone model predictive control. AP, CHO, s.c
15  2012 Coverage of prandial insulin requirements by means of an ultra-rapid-acting inhaled insulin. ---
16  2012 Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial. FVC, TLC
17  2012 Technosphere insulin effectively controls postprandial glycemia in patients with type 2 diabetes mellitus. CHO, MC, PPG
18  2011 Insulin lung deposition and clearance following Technosphere insulin inhalation powder administration. BAL, ELF, FDKP
19  2011 New ways of insulin delivery. ARIA, OI, PD, PK, RHI, s.c
20  2011 Population pharmacokinetic model of human insulin following different routes of administration. ---
21  2010 Insulin pharmacokinetics following dosing with Technosphere insulin in subjects with chronic obstructive pulmonary disease. COPD
22  2009 Inspiratory efforts achieved in use of the Technosphere insulin inhalation system. PIF, PIP, SD
23  2009 Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin. AUC, PD, PK, RHI, s.c
24  2009 Technosphere insulin: defining the role of Technosphere particles at the cellular level. ---
25  2008 Inhaled Technosphere insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes. ---
26  2008 Randomized forced titration to different doses of technosphere insulin demonstrates reduction in postprandial glucose excursions and hemoglobin A1c in patients with type 2 diabetes. HbA1c
27  2007 Technosphere insulin technology. ---
28  2005 Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism. ---